153 related articles for article (PubMed ID: 21727213)
1. Peri-ictal pseudoprogression in patients with brain tumor.
Rheims S; Ricard D; van den Bent M; Taillandier L; Bourg V; Désestret V; Cartalat-Carel S; Hermier M; Monjour A; Delattre JY; Sanson M; Honnorat J; Ducray F
Neuro Oncol; 2011 Jul; 13(7):775-82. PubMed ID: 21727213
[TBL] [Abstract][Full Text] [Related]
2. Peri-ictal pseudoprogression [pipg] in an operated case of right frontal glioma; case report and review of literature.
Maramattom BV; Panikar D
Neurol India; 2014; 62(4):467-9. PubMed ID: 25237971
[No Abstract] [Full Text] [Related]
3. Transient postictal MRI changes in patients with brain tumors may mimic disease progression.
Finn MA; Blumenthal DT; Salzman KL; Jensen RL
Surg Neurol; 2007 Mar; 67(3):246-50; discussion 250. PubMed ID: 17320628
[TBL] [Abstract][Full Text] [Related]
4. Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy.
van West SE; de Bruin HG; van de Langerijt B; Swaak-Kragten AT; van den Bent MJ; Taal W
Neuro Oncol; 2017 May; 19(5):719-725. PubMed ID: 28453748
[TBL] [Abstract][Full Text] [Related]
5. Contrast enhancing spots as a new pattern of late onset pseudoprogression in glioma patients.
Voss M; Franz K; Steinbach JP; Fokas E; Forster MT; Filipski K; Hattingen E; Wagner M; Breuer S
J Neurooncol; 2019 Mar; 142(1):161-169. PubMed ID: 30604393
[TBL] [Abstract][Full Text] [Related]
6. Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies.
Tsien C; Gomez-Hassan D; Ten Haken RK; Tatro D; Junck L; Chenevert TL; Lawrence T
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):328-32. PubMed ID: 15890571
[TBL] [Abstract][Full Text] [Related]
7. A prospective interventional study evaluating seizure activity during a radiotherapy course for high-grade gliomas (SURF-ROGG).
Rades D; Witteler J; Olbrich D; Trillenberg P; Schild SE; Tvilsted S; Kjaer TW
BMC Cancer; 2021 Apr; 21(1):386. PubMed ID: 33836671
[TBL] [Abstract][Full Text] [Related]
8. Seizures during the management of high-grade gliomas: clinical relevance to disease progression.
Kim YH; Park CK; Kim TM; Choi SH; Kim YJ; Choi BS; Han JH; Lee SH; Kim CY; Kim IA; Heo DS; Kim IH; Kim DG; Jung HW
J Neurooncol; 2013 May; 113(1):101-9. PubMed ID: 23459994
[TBL] [Abstract][Full Text] [Related]
9. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.
Fitzek MM; Thornton AF; Harsh G; Rabinov JD; Munzenrider JE; Lev M; Ancukiewicz M; Bussiere M; Hedley-Whyte ET; Hochberg FH; Pardo FS
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):131-7. PubMed ID: 11516862
[TBL] [Abstract][Full Text] [Related]
10. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
12. Seizures and Tumor Progression in Glioma Patients with Uncontrollable Epilepsy Treated with Perampanel.
Izumoto S; Miyauchi M; Tasaki T; Okuda T; Nakagawa N; Nakano N; Kato A; Fujita M
Anticancer Res; 2018 Jul; 38(7):4361-4366. PubMed ID: 29970574
[TBL] [Abstract][Full Text] [Related]
13. Cerebral blood flow changes after radiation therapy identifies pseudoprogression in diffuse intrinsic pontine gliomas.
Calmon R; Puget S; Varlet P; Dangouloff-Ros V; Blauwblomme T; Beccaria K; Grevent D; Sainte-Rose C; Castel D; Debily MA; Dufour C; Bolle S; Dhermain F; Saitovitch A; Zilbovicius M; Brunelle F; Grill J; Boddaert N
Neuro Oncol; 2018 Jun; 20(7):994-1002. PubMed ID: 29244086
[TBL] [Abstract][Full Text] [Related]
14. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.
Thomas AA; Arevalo-Perez J; Kaley T; Lyo J; Peck KK; Shi W; Zhang Z; Young RJ
J Neurooncol; 2015 Oct; 125(1):183-90. PubMed ID: 26275367
[TBL] [Abstract][Full Text] [Related]
16. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
[TBL] [Abstract][Full Text] [Related]
17. Brainstem gliomas in adults: prognostic factors and classification.
Guillamo JS; Monjour A; Taillandier L; Devaux B; Varlet P; Haie-Meder C; Defer GL; Maison P; Mazeron JJ; Cornu P; Delattre JY;
Brain; 2001 Dec; 124(Pt 12):2528-39. PubMed ID: 11701605
[TBL] [Abstract][Full Text] [Related]
18. Perioperative seizure in patients with glioma is associated with longer hospitalization, higher readmission, and decreased overall survival.
Dewan MC; White-Dzuro GA; Brinson PR; Thompson RC; Chambless LB
J Neurosurg; 2016 Oct; 125(4):1033-1041. PubMed ID: 26894454
[TBL] [Abstract][Full Text] [Related]
19. Patterns of tumor progression after radiotherapy for low-grade gliomas: analysis from the computed tomography/magnetic resonance imaging era.
Rudoler S; Corn BW; Werner-Wasik M; Flanders A; Preston PE; Tupchong L; Curran WJ
Am J Clin Oncol; 1998 Feb; 21(1):23-7. PubMed ID: 9499251
[TBL] [Abstract][Full Text] [Related]
20. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
